Category: Medical Issues for Men (Page 34 of 38)

Vaccines for the Brain

It’s that time of year again, flu season.? Millions will be getting their flu shots because their told they should by the medical establishment.? But, should you?? I know I won’t.

One of the world’s leading immunologists, Dr. Hugh Fudenberg, conducted studies that found that people who receive the flu vaccine yearly for three to five years increase their risk of Alzheimer’s disease tenfold.

He suggests the culprits are mercury and aluminum in the vaccines. Mercury and aluminum are directly toxic to brain cells and also over-stimulate the brain’s immune system. There is compelling evidence that this mechanism can trigger Alzheimer’s dementia, Parkinson’s disease, Lou Gehrig’s disease and autism spectrum disorders, as well as Gulf War Syndrome.?

In addition, the mercury in childhood vaccines, as well as adult vaccines such as flu vaccines, accumulates in the brain and is very difficult to remove. The idea of having yearly mercury injections is insane, to say the least, but millions still willingly line up for their annual flu shot.

NewsMax Health?Alert?

Is there any alternatives to getting vaccines?? How about eating a diet consisting of whole natural foods and exercising.

Bill Maher and Pharmaceuticals

I am not a big fan of Bill Maher’s.? He’s so off, wrong, most of the time it’s too painful for me to watch.? Yet, However devoid of logic his views are, they can be entertaining.? If you’ve ever seen his show you know that he ends with a short rant.? The following is Bill’s?take on exercise, pharmaceuticals and health in America.? Although serious in nature, he offers a hilarious slant.?

http://www.youtube.com/watch?v=rHXXTCc-IVg

Is the Pharmaceutical Industry paying U.S. Medical School Dept. Heads?

Taken from Vitamin Research Products online article Library:?

A new survey indicates that almost two thirds of department heads at U.S. medical schools have financial ties to drug companies.

The survey, conducted by researchers at Massachusetts General Hospital and Harvard Medical School, was distributed to all 125 accredited medical schools and the nation’s largest teaching hospitals. A total of 459 of 688 eligible department chairs completed the survey.

The results indicated that many of the academic leaders at these institutions served as paid consultants to the pharmaceutical industry or accepted free meals and drinks from drug company representatives. Overall, 60 percent of the department heads had a personal financial relationship with the drug companies. Twenty-seven percent reported serving as a paid consultant to the pharmaceutical industry and an equivalent amount of respondents also reported serving on a drug company scientific advisory board. Furthermore, 21 percent of these academic leaders reported serving on speakers’ bureaus for the drug industry. Eleven percent of respondents were on the board of directors of companies involved in the medical industry. In short, the survey found that pharmaceutical companies are involved in every aspect of medical care.

The lead author of the study, Eric Campbell, pointed out that drug companies and makers of medical devices often take advantage of these academic connections to convince physicians to widely prescribe the companies’ products to patients, even if the products aren’t necessarily in the patients’ best interest. Campbell also co-authored a study last year, which found that these same links to drug companies occur on hospital review boards that oversee experiments on patients.?

Reference:

Campbell EG, Weissman JS, Ehringhaus S, Rao SR, Moy B, Feibelmann S, Goold SD. Institutional academic industry relationships. JAMA. 2007 Oct 17;298(15):1779-86.

More Reasons to Stay Away from Statins.

Pharmaceutical companies continue to push cholesterol lowering drugs.? And doctors, who are brain washed, continue to prescribe them with a vengeance.? This, despite the fact, the evidence has never supported their use and continues to show how detrimental to ones health they are.

The following is taken from Wise Traditions, 2007; 8(3).

Most serious is the accumulating evidence that cholesterol lowering is bad for our brains.? One new study indicates that a decline in total cholesterol levels precedes diagnosis of dementia by at least 15 years (Archives of Neurology 2007; 64:103-107).? Evidence that low levels of LDL-cholesterol are associated with Parkinson’s disease have become so strong that a team at the University of North Carolina is planning to explore the link with clinical trials involving thousands of subjects (Reuters, January 15, 2007).? Cholesterol circulating in the bloodstream is unavailable to the brain-both LDL and HDL are too large to pass the blood brain barrier, so cholesterol needed by the brain must be manufactured in the brain.? Statins, however, do pass the barrier and enter the brain where they can interfere with cholesterol production and set the scene for cognitive decline.

Diabetes and Stroke Risk

Individuals diagnosed with Type 2 diabetes are at double the risk of having a stroke compared to those without diabetes, according to new research from the University of Alberta. It was found that the risk of a stroke is considered high within the first five years of treatment for Type 2 diabetes and more than doubles the rate of occurrence.

Research that recently appeared in the American Heart Association’s Stroke journal used 12,272 subjects in a Type 2 diabetes cohort.? All subjects were recently diagnosed with Type 2 diabetes and had a mean age of 64 years. After five years of monitoring, stroke incidence rates were compared between the cohort and the general population.

It is more common to study stroke prevalence within 10 years after diagnosis, this is the first study to specifically examine stroke-related outcomes immediately after the diagnosis of and initiation of treatment for Type 2 diabetes.? Researchers found that 9.1% of the diabetes cohort had a stroke within the first five years of their diagnosis,” Dr. Thomas Jeerakathil, an assistant professor in neurology, at the University of Alberta. “We also found that compared to persons from the general population of a similar age, the relative risk for stroke was much greater in younger persons with diabetes than for older persons.

Researchers hope their findings dispel the notion that the risk of stroke occurs only after the long term and will motivate both the patients and health care providersnto aggressively control risk factors after diagnosis.

Newsmax.com Health Alerts

« Older posts Newer posts »